Robert F. Werner - 08 Jun 2026 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Jun 2026, 16:05:02 UTC
Prior SEC filing
28 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kendra Fox, as Attorney-in-Fact for Robert F. Werner

Key filing fact

Robert F. Werner filed Form 4 for Twist Bioscience Corp (TWST) on 10 Jun 2026.

Key facts

  • This page summarizes Robert F. Werner's Form 4 filing for Twist Bioscience Corp (TWST).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Jun 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 28 May 2026.
  • Current net transaction value: -$94,046.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001590947 Primary reporting owner

WERNER ROBERT F.

Relationship
Chief Accounting Officer
Address
C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD, SOUTH SAN FRANCISCO
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Robert F. Werner
Signature date
10 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TWST transaction

Common Stock

Sale

Transaction value
$16,204
Shares
-232
Change %
-0.48%
Price
$69.84
Shares after
47,954
Date
08 Jun 2026
Ownership
Direct
Footnotes
F1
TWST transaction

Common Stock

Sale

Transaction value
$77,842
Shares
-1,127
Change %
-2.4%
Price
$69.07
Shares after
46,827
Date
08 Jun 2026
Ownership
Direct
TWST transaction

Common Stock

Gift

Transaction value
Shares
-500
Change %
-1.1%
Price
$0.000000*
Shares after
46,327
Date
08 Jun 2026
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Footnote F2

Represents a bona fide gift of shares to a charitable organization.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .